Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

lyrica

High Court rules against Pfizer in Lyrica patent case

September 10, 2015
Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin

The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …

News
pfizer_hq_new_york

Pfizer completes $15 billion Hospira acquisition

September 4, 2015
Biosimilar Drugs, Hospira, Pfizer, mergers and acquisitions

Pfizer has completed its acquisition of Illinois-based injectable drugs and infusion device specialist Hospira for around $15 billion.The deal, first announced …

News
alvogen_drugs_generic

Alvogen buys four-drug portfolio from Pfizer

August 27, 2015
Sales and Marketing Alvogen, Pfizer

Alvogen has entered into a agreement with Pfizer to purchase a portfolio of four pharmaceutical products for the US market, …

News
Pharma pill manufacturing

FDA hits Mylan’s Indian plants with warning letter

August 20, 2015
Manufacturing and Production Contamination, FDA, Mylan, Pfizer, manufacturing, production

The FDA has served Mylan with a warning letter citing contamination at three of its manufacturing facilities in India. Inspections …

News
Pfizer image

Pfizer offers to pay for UK Lyrica switches

August 13, 2015
Lyrica, NHS England, Pfizer, generics, neuropathic pain, patents, pregabalin

Pfizer is to pay the administrative costs of GPs to switch patients to Lyrica from generic versions of pregabalin, as …

News

Pfizer and Flynn rapped for overcharging on anti-epilepsy drug

August 6, 2015
Manufacturing and Production, Sales and Marketing CMA, Drug pricing, Flynn Pharma, Pfizer, competitions markets authority, epilepsy, generics, phenytoin, pricing

Pharma firms Pfizer and Flynn Pharma have been accused by the UK’s competition watchdog of charging ‘excessive and unfair’ prices …

News

Novartis and Pfizer to close factories in India

July 21, 2015
Manufacturing and Production India, Novartis, Pfizer, Sandoz, manufacturing

Two big pharma firms have announced they will close manufacturing facilities in India as they seek to restructures their global …

News
Professor Dame Sally Davies

Pfizer partners with NIHR to boosts UK R&D

July 1, 2015
Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies

Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …

News

Pfizer acquires meningitis vaccines from GSK

June 23, 2015
Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, Pfizer, meningitis

Pharma giants GSK and Pfizer have announced an agreement to transfer the ownership of two meningitis vaccines from GlaxoSmithKline to …

News
GSK image

GSK ploughs $95m into research institute

June 17, 2015
Research and Development, Sales and Marketing GSK, Pfizer, acquisition, altius, merger, takeover

GlaxoSmithKline is pouring $95 million into a new US research institute to investigate how a cell’s operating system works in …

News
Pfizer image

Pfizer expands in China with $95m consumer products plant

June 16, 2015
Manufacturing and Production, Sales and Marketing Asia, China, Pfizer, brett wells, production

Pfizer says it has broken ground with a $95 million production facility in Suzhou in China to expand its production …

News

Pfizer breast cancer drug delivers

June 1, 2015
Sales and Marketing ASCO, AZ, Faslodex, Pfizer, breast cancer, brett wells

A Phase III study on Pfizer’s treatment Ibrance in combination with hormone therapy has revealed the drug more than doubled …

News
Pfizer image

Pfizer gets first approval for rare lung disease

May 29, 2015
Sales and Marketing FDA, Pfizer, Rapamune, lung disease

Pfizer’s Rapamune will become the first drug available to treat the very rare lung disease lymphangioleiomyomatosis (LAM) after receiving approval …

News

Analysts predict Pfizer to swallow GSK

May 21, 2015
Sales and Marketing AZ, GSK, GlaxoSmithKline, Pfizer, merger

GlaxoSmithKline has been suggested as a potential M&A target for Pfizer, despite the US company backing out of a similar …

News
marc_tessier-lavigne

Pfizer board member stepping down

May 21, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Marc Tessier-Lavigne, Pfizer

Dr Marc Tessier-Lavigne is leaving Pfizer’s board of directors to work on the launch of Denali, a new biotech company …

Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026